<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-08-14" modified="2020-10-07" version="200">
<accession>O75533</accession>
<accession>E9PCH3</accession>
<name>SF3B1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Splicing factor 3B subunit 1</fullName>
</recommendedName>
<alternativeName>
<fullName>Pre-mRNA-splicing factor SF3b 155 kDa subunit</fullName>
<shortName>SF3b155</shortName>
</alternativeName>
<alternativeName>
<fullName>Spliceosome-associated protein 155</fullName>
<shortName>SAP 155</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SF3B1</name>
<name type="synonym">SAP155</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Genes Dev." volume="12" first="1409" last="1414">
<title>Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis.</title>
<authorList>
<person name="Wang C."/>
<person name="Chua K."/>
<person name="Seghezzi W."/>
<person name="Lees E."/>
<person name="Gozani O."/>
<person name="Reed R."/>
</authorList>
<dbReference type="PubMed" id="9585501"/>
<dbReference type="DOI" id="10.1101/gad.12.10.1409"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="2">
<citation type="submission" date="1998-09" db="EMBL/GenBank/DDBJ databases">
<title>Full clone sequencing of the longest available member from each UniGene cluster.</title>
<authorList>
<person name="Woessner J."/>
<person name="Tan F."/>
<person name="Marra M."/>
<person name="Kucaba T."/>
<person name="Yandell M."/>
<person name="Martin J."/>
<person name="Marth G."/>
<person name="Bowles L."/>
<person name="Wylie T."/>
<person name="Bowers Y."/>
<person name="Steptoe M."/>
<person name="Theising B."/>
<person name="Geisel S."/>
<person name="Allen M."/>
<person name="Underwood K."/>
<person name="Chappell J."/>
<person name="Person B."/>
<person name="Gibbons M."/>
<person name="Harvey N."/>
<person name="Pape D."/>
<person name="Chamberlain A."/>
<person name="Morales R."/>
<person name="Schurk R."/>
<person name="Ritter E."/>
<person name="Kohn S."/>
<person name="Swaller T."/>
<person name="Behymer K."/>
<person name="Hillier L."/>
<person name="Wilson R."/>
<person name="Waterston R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="1998-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Yu W."/>
<person name="Gibbs R.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1011-1304 (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2000" name="Mol. Cell" volume="5" first="779" last="787">
<title>Functional association of U2 snRNP with the ATP-independent spliceosomal complex E.</title>
<authorList>
<person name="Das R."/>
<person name="Zhou Z."/>
<person name="Reed R."/>
</authorList>
<dbReference type="PubMed" id="10882114"/>
<dbReference type="DOI" id="10.1016/s1097-2765(00)80318-4"/>
</citation>
<scope>CHARACTERIZATION OF THE SPLICEOSOME</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="4978" last="4988">
<title>Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD-box protein.</title>
<authorList>
<person name="Will C.L."/>
<person name="Urlaub H."/>
<person name="Achsel T."/>
<person name="Gentzel M."/>
<person name="Wilm M."/>
<person name="Luehrmann R."/>
</authorList>
<dbReference type="PubMed" id="12234937"/>
<dbReference type="DOI" id="10.1093/emboj/cdf480"/>
</citation>
<scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="31834" last="31841">
<title>Phosphorylation-dependent interaction between the splicing factors SAP155 and NIPP1.</title>
<authorList>
<person name="Boudrez A."/>
<person name="Beullens M."/>
<person name="Waelkens E."/>
<person name="Stalmans W."/>
<person name="Bollen M."/>
</authorList>
<dbReference type="PubMed" id="12105215"/>
<dbReference type="DOI" id="10.1074/jbc.m204427200"/>
</citation>
<scope>INTERACTION WITH PPP1R8</scope>
<scope>PHOSPHORYLATION AT THR-244; THR-248 AND THR-313</scope>
<scope>MUTAGENESIS OF THR-223; THR-227; THR-235; THR-244; THR-248; THR-257; THR-261; THR-267; THR-273; THR-278; THR-296; THR-303 AND THR-313</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="RNA" volume="8" first="426" last="439">
<title>Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.</title>
<authorList>
<person name="Jurica M.S."/>
<person name="Licklider L.J."/>
<person name="Gygi S.P."/>
<person name="Grigorieff N."/>
<person name="Moore M.J."/>
</authorList>
<dbReference type="PubMed" id="11991638"/>
<dbReference type="DOI" id="10.1017/s1355838202021088"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE SPLICEOSOMAL C COMPLEX</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Science" volume="300" first="980" last="984">
<title>Molecular architecture of the multiprotein splicing factor SF3b.</title>
<authorList>
<person name="Golas M.M."/>
<person name="Sander B."/>
<person name="Will C.L."/>
<person name="Luhrmann R."/>
<person name="Stark H."/>
</authorList>
<dbReference type="PubMed" id="12738865"/>
<dbReference type="DOI" id="10.1126/science.1084155"/>
</citation>
<scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
<scope>ELECTRON MICROSCOPY OF THE SF3B COMPLEX</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="RNA" volume="10" first="929" last="941">
<title>The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome.</title>
<authorList>
<person name="Will C.L."/>
<person name="Schneider C."/>
<person name="Hossbach M."/>
<person name="Urlaub H."/>
<person name="Rauhut R."/>
<person name="Elbashir S."/>
<person name="Tuschl T."/>
<person name="Luehrmann R."/>
</authorList>
<dbReference type="PubMed" id="15146077"/>
<dbReference type="DOI" id="10.1261/rna.7320604"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH THE U11/U12 SPLICEOSOME</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-211; THR-223; THR-296 AND THR-299</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="16264" last="16271">
<title>The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription.</title>
<authorList>
<person name="Cavellan E."/>
<person name="Asp P."/>
<person name="Percipalle P."/>
<person name="Oestlund Farrants A.-K."/>
</authorList>
<dbReference type="PubMed" id="16603771"/>
<dbReference type="DOI" id="10.1074/jbc.m600233200"/>
</citation>
<scope>IDENTIFICATION IN THE B-WICH COMPLEX</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-207; THR-211 AND THR-328</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-142 AND THR-223</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-223 AND THR-267</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-354</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; THR-142; SER-194; THR-207; THR-211; THR-223; THR-227; THR-326; THR-328; SER-332 AND SER-488</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-207; THR-211; THR-223; THR-227; THR-326; THR-341; SER-349; THR-350; SER-400; THR-434 AND THR-436</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-141; LYS-554 AND LYS-562</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; SER-194; THR-203; THR-207; THR-211; THR-223; THR-326; THR-328 AND SER-488</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Mol. Cell" volume="42" first="794" last="805">
<title>Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination.</title>
<authorList>
<person name="Skourti-Stathaki K."/>
<person name="Proudfoot N.J."/>
<person name="Gromak N."/>
</authorList>
<dbReference type="PubMed" id="21700224"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.04.026"/>
</citation>
<scope>INTERACTION WITH SETX</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; THR-211; THR-341; SER-344; SER-349 AND THR-354</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="Genes Dev." volume="27" first="615" last="626">
<title>PQBP1, a factor linked to intellectual disability, affects alternative splicing associated with neurite outgrowth.</title>
<authorList>
<person name="Wang Q."/>
<person name="Moore M.J."/>
<person name="Adelmant G."/>
<person name="Marto J.A."/>
<person name="Silver P.A."/>
</authorList>
<dbReference type="PubMed" id="23512658"/>
<dbReference type="DOI" id="10.1101/gad.212308.112"/>
</citation>
<scope>INTERACTION WITH PQBP1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-125; SER-129; THR-142; SER-194; THR-207; THR-211; THR-223; THR-227; THR-235; THR-257; THR-261; THR-267; THR-278; THR-296; THR-303; THR-313; SER-322; THR-326; SER-332; THR-350; THR-354; SER-400; THR-426; THR-434; THR-436 AND SER-488</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; THR-211; THR-257; THR-261; THR-267; THR-273; THR-278; SER-287; THR-303; THR-313 AND SER-488</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-413</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-413</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2015" name="Elife" volume="4">
<title>Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing.</title>
<authorList>
<person name="Zhang L."/>
<person name="Tran N.T."/>
<person name="Su H."/>
<person name="Wang R."/>
<person name="Lu Y."/>
<person name="Tang H."/>
<person name="Aoyagi S."/>
<person name="Guo A."/>
<person name="Khodadadi-Jamayran A."/>
<person name="Zhou D."/>
<person name="Qian K."/>
<person name="Hricik T."/>
<person name="Cote J."/>
<person name="Han X."/>
<person name="Zhou W."/>
<person name="Laha S."/>
<person name="Abdel-Wahab O."/>
<person name="Levine R.L."/>
<person name="Raffel G."/>
<person name="Liu Y."/>
<person name="Chen D."/>
<person name="Li H."/>
<person name="Townes T."/>
<person name="Wang H."/>
<person name="Deng H."/>
<person name="Zheng Y.G."/>
<person name="Leslie C."/>
<person name="Luo M."/>
<person name="Zhao X."/>
</authorList>
<dbReference type="PubMed" id="26575292"/>
<dbReference type="DOI" id="10.7554/elife.07938"/>
</citation>
<scope>INTERACTION WITH RBM15</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-413</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2017" name="Nat. Commun." volume="8" first="15522" last="15522">
<title>Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex.</title>
<authorList>
<person name="Teng T."/>
<person name="Tsai J.H."/>
<person name="Puyang X."/>
<person name="Seiler M."/>
<person name="Peng S."/>
<person name="Prajapati S."/>
<person name="Aird D."/>
<person name="Buonamici S."/>
<person name="Caleb B."/>
<person name="Chan B."/>
<person name="Corson L."/>
<person name="Feala J."/>
<person name="Fekkes P."/>
<person name="Gerard B."/>
<person name="Karr C."/>
<person name="Korpal M."/>
<person name="Liu X."/>
<person name="Lowe J.T."/>
<person name="Mizui Y."/>
<person name="Palacino J."/>
<person name="Park E."/>
<person name="Smith P.G."/>
<person name="Subramanian V."/>
<person name="Wu Z.J."/>
<person name="Zou J."/>
<person name="Yu L."/>
<person name="Chicas A."/>
<person name="Warmuth M."/>
<person name="Larsen N."/>
<person name="Zhu P."/>
</authorList>
<dbReference type="PubMed" id="28541300"/>
<dbReference type="DOI" id="10.1038/ncomms15522"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-214; LYS-413 AND LYS-430</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="1266" last="1271">
<title>Crystal structure of a core spliceosomal protein interface.</title>
<authorList>
<person name="Schellenberg M.J."/>
<person name="Edwards R.A."/>
<person name="Ritchie D.B."/>
<person name="Kent O.A."/>
<person name="Golas M.M."/>
<person name="Stark H."/>
<person name="Luhrmann R."/>
<person name="Glover J.N."/>
<person name="MacMillan A.M."/>
</authorList>
<dbReference type="PubMed" id="16432215"/>
<dbReference type="DOI" id="10.1073/pnas.0508048103"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 373-415 IN COMPLEX WITH SF3B6</scope>
<scope>INTERACTION WITH SF3B6</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="Nat. Struct. Mol. Biol." volume="14" first="620" last="629">
<title>U2AF-homology motif interactions are required for alternative splicing regulation by SPF45.</title>
<authorList>
<person name="Corsini L."/>
<person name="Bonnal S."/>
<person name="Basquin J."/>
<person name="Hothorn M."/>
<person name="Scheffzek K."/>
<person name="Valcarcel J."/>
<person name="Sattler M."/>
</authorList>
<dbReference type="PubMed" id="17589525"/>
<dbReference type="DOI" id="10.1038/nsmb1260"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.11 ANGSTROMS) OF 333-342 IN COMPLEX WITH RBM17</scope>
<scope>INTERACTION WITH RBM17</scope>
</reference>
<reference key="36">
<citation type="submission" date="2007-01" db="PDB data bank">
<title>NMR solution structure of the human spliceosomal protein complex p14-SF3B155.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 379-424 IN COMPLEX WITH SF3B6</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="RNA" volume="17" first="155" last="165">
<title>Structural model of the p14/SF3b155 - branch duplex complex.</title>
<authorList>
<person name="Schellenberg M.J."/>
<person name="Dul E.L."/>
<person name="MacMillan A.M."/>
</authorList>
<dbReference type="PubMed" id="21062891"/>
<dbReference type="DOI" id="10.1261/rna.2224411"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.38 ANGSTROMS) OF 377-415 IN COMPLEX WITH SF3B6</scope>
<scope>INTERACTION WITH SF3B6</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="17325" last="17337">
<title>Cancer-relevant splicing factor CAPERalpha engages the essential splicing factor SF3b155 in a specific ternary complex.</title>
<authorList>
<person name="Loerch S."/>
<person name="Maucuer A."/>
<person name="Manceau V."/>
<person name="Green M.R."/>
<person name="Kielkopf C.L."/>
</authorList>
<dbReference type="PubMed" id="24795046"/>
<dbReference type="DOI" id="10.1074/jbc.m114.558825"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.74 ANGSTROMS) OF 333-342 IN COMPLEX WITH RBM39</scope>
<scope>INTERACTION WITH RBM39</scope>
<scope>MUTAGENESIS OF TRP-200; TRP-218; TRP-232; TRP-254; TRP-293; TRP-310 AND TRP-338</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2016" name="Mol. Cell" volume="64" first="307" last="319">
<title>Molecular architecture of SF3b and structural consequences of its cancer-related mutations.</title>
<authorList>
<person name="Cretu C."/>
<person name="Schmitzova J."/>
<person name="Ponce-Salvatierra A."/>
<person name="Dybkov O."/>
<person name="De Laurentiis E.I."/>
<person name="Sharma K."/>
<person name="Will C.L."/>
<person name="Urlaub H."/>
<person name="Luehrmann R."/>
<person name="Pena V."/>
</authorList>
<dbReference type="PubMed" id="27720643"/>
<dbReference type="DOI" id="10.1016/j.molcel.2016.08.036"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) IN COMPLEX WITH SF3B3; SF3B5 AND PHF5A</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SF3B3; SF3B5 AND PHF5A</scope>
<scope>IDENTIFICATION IN THE SF3B COMPLEX</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>RNA-BINDING</scope>
<scope>MUTAGENESIS OF LYS-700</scope>
</reference>
<comment type="function">
<text evidence="22 23 26 28 37">Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex (PubMed:27720643). SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). Together with other U2 snRNP complex components may also play a role in the selective processing of microRNAs (miRNAs) from the long primary miRNA transcript, pri-miR-17-92 (By similarity). May also be involved in the assembly of the 'E' complex (PubMed:10882114). Belongs also to the minor U12-dependent spliceosome, which is involved in the splicing of rare class of nuclear pre-mRNA intron (PubMed:15146077).</text>
</comment>
<comment type="subunit">
<text evidence="24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 40">Component of the B-WICH complex, at least composed of SMARCA5/SNF2H, BAZ1B/WSTF, SF3B1, DEK, MYO1C, ERCC6, MYBBP1A and DDX21 (PubMed:16603771). Identified in the spliceosome C complex (PubMed:11991638). Component of the U11/U12 snRNPs that are part of the U12-type spliceosome (PubMed:15146077). Component of splicing factor SF3B complex which is composed of at least eight subunits; SF3B1, SF3B2, SF3B3, SF3B4, SF3B5, SF3B6, PHF5A and DDX42 (PubMed:12234937, PubMed:12738865, PubMed:28541300, PubMed:27720643). SF3B associates with the splicing factor SF3A and a 12S RNA unit to form the U2 small nuclear ribonucleoproteins complex (U2 snRNP). Interacts directly with the splicing factor U2AF (PubMed:12234937). Within the SF3B complex interacts directly (via HEAT domain) with SF3B3, SF3B5 and (via HEAT domain) with PHF5A (PubMed:27720643). Interacts directly with SF3B6 (PubMed:16432215, Ref.36, PubMed:21062891). The SF3B complex composed of SF3B1, SF3B2, SF3B3, SF3B4, SF3B5, SF3B6 and PHF5A interacts with U2AF2 (PubMed:27720643). Phosphorylated form interacts with PPP1R8 (PubMed:12105215). Interacts with PQBP1 (PubMed:23512658). Interacts with RBM17 (PubMed:17589525). Interacts with RBM39 (PubMed:24795046). Interacts with SETX (PubMed:21700224). Interacts with RBM15 (PubMed:26575292).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-876542">
<id>O75533</id>
</interactant>
<interactant intactId="EBI-740272">
<id>Q96I25</id>
<label>RBM17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15565798">
<id>O75533-1</id>
</interactant>
<interactant intactId="EBI-740272">
<id>Q96I25</id>
<label>RBM17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15565798">
<id>O75533-1</id>
</interactant>
<interactant intactId="EBI-1046261">
<id>Q9Y3B4</id>
<label>SF3B6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="37 38">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus speckle</location>
</subcellularLocation>
<text>During mitosis, transiently dispersed from the nuclear speckles to the cytoplasm.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O75533-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O75533-2</id>
<name>2</name>
<sequence type="described" ref="VSP_046182 VSP_046183"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="25 39">Phosphorylated. Phosphorylation occurs concomitantly with the splicing catalytic steps. Phosphorylation on Thr-244, Thr-248 and Thr-313 by cyclin-dependent kinases promotes interaction with PPP1R8 during mitosis.</text>
</comment>
<comment type="PTM">
<text evidence="21">Citrullinated by PADI4.</text>
</comment>
<comment type="similarity">
<text evidence="42">Belongs to the SF3B1 family.</text>
</comment>
<dbReference type="EMBL" id="AF054284">
<property type="protein sequence ID" value="AAC97189.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF086296">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC010746">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF070540">
<property type="protein sequence ID" value="AAC28633.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33356.1">
<molecule id="O75533-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46479.1">
<molecule id="O75533-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_036565.2">
<molecule id="O75533-1"/>
<property type="nucleotide sequence ID" value="NM_012433.3"/>
</dbReference>
<dbReference type="PDB" id="2F9D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="P/Q=373-415"/>
</dbReference>
<dbReference type="PDB" id="2F9J">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="P/Q=380-415"/>
</dbReference>
<dbReference type="PDB" id="2FHO">
<property type="method" value="NMR"/>
<property type="chains" value="A=379-424"/>
</dbReference>
<dbReference type="PDB" id="2PEH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.11"/>
<property type="chains" value="C/D=333-342"/>
</dbReference>
<dbReference type="PDB" id="3LQV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.38"/>
<property type="chains" value="P/Q=377-415"/>
</dbReference>
<dbReference type="PDB" id="4OZ1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.74"/>
<property type="chains" value="C=333-342"/>
</dbReference>
<dbReference type="PDB" id="5IFE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="C=1-1304"/>
</dbReference>
<dbReference type="PDB" id="5O9Z">
<property type="method" value="EM"/>
<property type="resolution" value="4.50"/>
<property type="chains" value="v=1-1304"/>
</dbReference>
<dbReference type="PDB" id="5Z56">
<property type="method" value="EM"/>
<property type="resolution" value="5.10"/>
<property type="chains" value="1=1-1304"/>
</dbReference>
<dbReference type="PDB" id="5Z57">
<property type="method" value="EM"/>
<property type="resolution" value="6.50"/>
<property type="chains" value="1=1-1304"/>
</dbReference>
<dbReference type="PDB" id="5Z58">
<property type="method" value="EM"/>
<property type="resolution" value="4.90"/>
<property type="chains" value="1=1-1304"/>
</dbReference>
<dbReference type="PDB" id="5ZYA">
<property type="method" value="EM"/>
<property type="resolution" value="3.95"/>
<property type="chains" value="C=1-1304"/>
</dbReference>
<dbReference type="PDB" id="6AH0">
<property type="method" value="EM"/>
<property type="resolution" value="5.70"/>
<property type="chains" value="1=1-1304"/>
</dbReference>
<dbReference type="PDB" id="6EN4">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.08"/>
<property type="chains" value="C=453-1304"/>
</dbReference>
<dbReference type="PDB" id="6FF4">
<property type="method" value="EM"/>
<property type="resolution" value="16.00"/>
<property type="chains" value="u=1-1304"/>
</dbReference>
<dbReference type="PDB" id="6FF7">
<property type="method" value="EM"/>
<property type="resolution" value="4.50"/>
<property type="chains" value="u=1-1304"/>
</dbReference>
<dbReference type="PDB" id="6N3E">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="B=291-297"/>
</dbReference>
<dbReference type="PDB" id="6QX9">
<property type="method" value="EM"/>
<property type="resolution" value="3.28"/>
<property type="chains" value="B1=1-1304"/>
</dbReference>
<dbReference type="PDB" id="6Y50">
<property type="method" value="EM"/>
<property type="resolution" value="4.10"/>
<property type="chains" value="u=1-1304"/>
</dbReference>
<dbReference type="PDB" id="6Y53">
<property type="method" value="EM"/>
<property type="resolution" value="7.10"/>
<property type="chains" value="u=1-1304"/>
</dbReference>
<dbReference type="PDB" id="6Y5Q">
<property type="method" value="EM"/>
<property type="resolution" value="7.10"/>
<property type="chains" value="u=1-1304"/>
</dbReference>
<dbReference type="PDBsum" id="2F9D"/>
<dbReference type="PDBsum" id="2F9J"/>
<dbReference type="PDBsum" id="2FHO"/>
<dbReference type="PDBsum" id="2PEH"/>
<dbReference type="PDBsum" id="3LQV"/>
<dbReference type="PDBsum" id="4OZ1"/>
<dbReference type="PDBsum" id="5IFE"/>
<dbReference type="PDBsum" id="5O9Z"/>
<dbReference type="PDBsum" id="5Z56"/>
<dbReference type="PDBsum" id="5Z57"/>
<dbReference type="PDBsum" id="5Z58"/>
<dbReference type="PDBsum" id="5ZYA"/>
<dbReference type="PDBsum" id="6AH0"/>
<dbReference type="PDBsum" id="6EN4"/>
<dbReference type="PDBsum" id="6FF4"/>
<dbReference type="PDBsum" id="6FF7"/>
<dbReference type="PDBsum" id="6N3E"/>
<dbReference type="PDBsum" id="6QX9"/>
<dbReference type="PDBsum" id="6Y50"/>
<dbReference type="PDBsum" id="6Y53"/>
<dbReference type="PDBsum" id="6Y5Q"/>
<dbReference type="BMRB" id="O75533"/>
<dbReference type="SMR" id="O75533"/>
<dbReference type="BioGRID" id="117017">
<property type="interactions" value="329"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1099">
<property type="entry name" value="B-WICH chromatin remodelling complex"/>
</dbReference>
<dbReference type="CORUM" id="O75533"/>
<dbReference type="DIP" id="DIP-29411N"/>
<dbReference type="ELM" id="O75533"/>
<dbReference type="IntAct" id="O75533">
<property type="interactions" value="98"/>
</dbReference>
<dbReference type="MINT" id="O75533"/>
<dbReference type="STRING" id="9606.ENSP00000335321"/>
<dbReference type="ChEMBL" id="CHEMBL1229013"/>
<dbReference type="DrugBank" id="DB14017">
<property type="generic name" value="H3B-8800"/>
</dbReference>
<dbReference type="iPTMnet" id="O75533"/>
<dbReference type="MetOSite" id="O75533"/>
<dbReference type="PhosphoSitePlus" id="O75533"/>
<dbReference type="SwissPalm" id="O75533"/>
<dbReference type="BioMuta" id="SF3B1"/>
<dbReference type="EPD" id="O75533"/>
<dbReference type="jPOST" id="O75533"/>
<dbReference type="MassIVE" id="O75533"/>
<dbReference type="MaxQB" id="O75533"/>
<dbReference type="PaxDb" id="O75533"/>
<dbReference type="PeptideAtlas" id="O75533"/>
<dbReference type="PRIDE" id="O75533"/>
<dbReference type="ProteomicsDB" id="19445"/>
<dbReference type="ProteomicsDB" id="50072">
<molecule id="O75533-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="19893">
<property type="antibodies" value="255 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000335508">
<molecule id="O75533-1"/>
<property type="protein sequence ID" value="ENSP00000335321"/>
<property type="gene ID" value="ENSG00000115524"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000409915">
<molecule id="O75533-2"/>
<property type="protein sequence ID" value="ENSP00000428820"/>
<property type="gene ID" value="ENSG00000115524"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000414963">
<molecule id="O75533-2"/>
<property type="protein sequence ID" value="ENSP00000402997"/>
<property type="gene ID" value="ENSG00000115524"/>
</dbReference>
<dbReference type="GeneID" id="23451"/>
<dbReference type="KEGG" id="hsa:23451"/>
<dbReference type="UCSC" id="uc002uue.4">
<molecule id="O75533-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="23451"/>
<dbReference type="DisGeNET" id="23451"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000115524.15"/>
<dbReference type="GeneCards" id="SF3B1"/>
<dbReference type="HGNC" id="HGNC:10768">
<property type="gene designation" value="SF3B1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000115524">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="SF3B1"/>
<dbReference type="MIM" id="605590">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O75533"/>
<dbReference type="OpenTargets" id="ENSG00000115524"/>
<dbReference type="Orphanet" id="75564">
<property type="disease" value="Acquired idiopathic sideroblastic anemia"/>
</dbReference>
<dbReference type="Orphanet" id="39044">
<property type="disease" value="Uveal melanoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA35686"/>
<dbReference type="eggNOG" id="KOG0213">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000018393"/>
<dbReference type="HOGENOM" id="CLU_002242_0_0_1"/>
<dbReference type="InParanoid" id="O75533"/>
<dbReference type="KO" id="K12828"/>
<dbReference type="OMA" id="RSRWDAT"/>
<dbReference type="PhylomeDB" id="O75533"/>
<dbReference type="TreeFam" id="TF105680"/>
<dbReference type="PathwayCommons" id="O75533"/>
<dbReference type="Reactome" id="R-HSA-5250924">
<property type="pathway name" value="B-WICH complex positively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72163">
<property type="pathway name" value="mRNA Splicing - Major Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72165">
<property type="pathway name" value="mRNA Splicing - Minor Pathway"/>
</dbReference>
<dbReference type="SIGNOR" id="O75533"/>
<dbReference type="BioGRID-ORCS" id="23451">
<property type="hits" value="644 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SF3B1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O75533"/>
<dbReference type="GeneWiki" id="SF3B1"/>
<dbReference type="GenomeRNAi" id="23451"/>
<dbReference type="Pharos" id="O75533">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O75533"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="O75533">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115524">
<property type="expression patterns" value="Expressed in small intestine Peyer's patch and 242 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O75533">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O75533">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0071013">
<property type="term" value="C:catalytic step 2 spliceosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005681">
<property type="term" value="C:spliceosomal complex"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034693">
<property type="term" value="C:U11/U12 snRNP"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005689">
<property type="term" value="C:U12-type spliceosomal complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005686">
<property type="term" value="C:U2 snRNP"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071005">
<property type="term" value="C:U2-type precatalytic spliceosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071004">
<property type="term" value="C:U2-type prespliceosome"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003729">
<property type="term" value="F:mRNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990935">
<property type="term" value="F:splicing factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000398">
<property type="term" value="P:mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045815">
<property type="term" value="P:positive regulation of gene expression, epigenetic"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008380">
<property type="term" value="P:RNA splicing"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000375">
<property type="term" value="P:RNA splicing, via transesterification reactions"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000245">
<property type="term" value="P:spliceosomal complex assembly"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="DisProt" id="DP01863"/>
<dbReference type="Gene3D" id="1.25.10.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="IDEAL" id="IID00190"/>
<dbReference type="InterPro" id="IPR011989">
<property type="entry name" value="ARM-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR016024">
<property type="entry name" value="ARM-type_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR015016">
<property type="entry name" value="SF3b_su1"/>
</dbReference>
<dbReference type="InterPro" id="IPR038737">
<property type="entry name" value="SF3b_su1-like"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR12097">
<property type="entry name" value="PTHR12097"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08920">
<property type="entry name" value="SF3b1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48371">
<property type="entry name" value="SSF48371"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0164">Citrullination</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0507">mRNA processing</keyword>
<keyword id="KW-0508">mRNA splicing</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0747">Spliceosome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Splicing factor 3B subunit 1" id="PRO_0000174323">
<location>
<begin position="1"/>
<end position="1304"/>
</location>
</feature>
<feature type="repeat" description="HEAT 1">
<location>
<begin position="529"/>
<end position="568"/>
</location>
</feature>
<feature type="repeat" description="HEAT 2">
<location>
<begin position="569"/>
<end position="603"/>
</location>
</feature>
<feature type="repeat" description="HEAT 3">
<location>
<begin position="604"/>
<end position="641"/>
</location>
</feature>
<feature type="repeat" description="HEAT 4">
<location>
<begin position="643"/>
<end position="677"/>
</location>
</feature>
<feature type="repeat" description="HEAT 5">
<location>
<begin position="680"/>
<end position="718"/>
</location>
</feature>
<feature type="repeat" description="HEAT 6">
<location>
<begin position="763"/>
<end position="801"/>
</location>
</feature>
<feature type="repeat" description="HEAT 7">
<location>
<begin position="843"/>
<end position="881"/>
</location>
</feature>
<feature type="repeat" description="HEAT 8">
<location>
<begin position="1010"/>
<end position="1048"/>
</location>
</feature>
<feature type="repeat" description="HEAT 9">
<location>
<begin position="1052"/>
<end position="1090"/>
</location>
</feature>
<feature type="repeat" description="HEAT 10">
<location>
<begin position="1122"/>
<end position="1160"/>
</location>
</feature>
<feature type="repeat" description="HEAT 11">
<location>
<begin position="1163"/>
<end position="1201"/>
</location>
</feature>
<feature type="region of interest" description="U2AF homology region; mediates interaction with RBM39" evidence="35">
<location>
<begin position="190"/>
<end position="342"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PPP1R8" evidence="25">
<location>
<begin position="223"/>
<end position="491"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SF3B14">
<location>
<begin position="529"/>
<end position="568"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PHF5A" evidence="37">
<location>
<begin position="547"/>
<end position="550"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PHF5A" evidence="37">
<location>
<begin position="1156"/>
<end position="1157"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SF3B3 and SF3B5" evidence="37">
<location>
<begin position="1248"/>
<end position="1304"/>
</location>
</feature>
<feature type="site" description="Interaction with RNA" evidence="37">
<location>
<position position="469"/>
</location>
</feature>
<feature type="site" description="Interaction with RNA" evidence="37">
<location>
<position position="587"/>
</location>
</feature>
<feature type="site" description="Interaction with PHF5A" evidence="37">
<location>
<position position="592"/>
</location>
</feature>
<feature type="site" description="Interaction with SF3B3" evidence="37">
<location>
<position position="602"/>
</location>
</feature>
<feature type="site" description="Interaction with SF3B3" evidence="37">
<location>
<position position="677"/>
</location>
</feature>
<feature type="site" description="Interaction with RNA" evidence="37">
<location>
<position position="1035"/>
</location>
</feature>
<feature type="site" description="Interaction with RNA" evidence="37">
<location>
<position position="1049"/>
</location>
</feature>
<feature type="site" description="Interaction with RNA" evidence="37">
<location>
<position position="1141"/>
</location>
</feature>
<feature type="site" description="Interaction with SF3B3" evidence="37">
<location>
<position position="1205"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="125"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 13 14 15 16">
<location>
<position position="129"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11">
<location>
<position position="141"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7 9 15">
<location>
<position position="142"/>
</location>
</feature>
<feature type="modified residue" description="Citrulline" evidence="21">
<location>
<position position="157"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 13 15">
<location>
<position position="194"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="203"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 9 12 13 15">
<location>
<position position="207"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 6 9 12 13 14 15 16">
<location>
<position position="211"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="22">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6 7 8 9 12 13 15">
<location>
<position position="223"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 12 15">
<location>
<position position="227"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="229"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="235"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="25">
<location>
<position position="244"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="43">
<location>
<position position="248"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15 16">
<location>
<position position="257"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15 16">
<location>
<position position="261"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8 15 16">
<location>
<position position="267"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16">
<location>
<position position="273"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15 16">
<location>
<position position="278"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="287"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6 15">
<location>
<position position="296"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="299"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15 16">
<location>
<position position="303"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15 16">
<location>
<position position="313"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="322"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 12 13 15">
<location>
<position position="326"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 9 13">
<location>
<position position="328"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 15">
<location>
<position position="332"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12 14">
<location>
<position position="341"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="344"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 14">
<location>
<position position="349"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12 15">
<location>
<position position="350"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 14 15">
<location>
<position position="354"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 15">
<location>
<position position="400"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="426"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12 15">
<location>
<position position="434"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12 15">
<location>
<position position="436"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 13 15 16">
<location>
<position position="488"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11">
<location>
<position position="554"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11">
<location>
<position position="562"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20">
<location>
<position position="214"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="17">
<location>
<position position="413"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="17 18 19 20">
<location>
<position position="413"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20">
<location>
<position position="430"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_046182" evidence="41">
<original>GKTPD</original>
<variation>FYSAA</variation>
<location>
<begin position="140"/>
<end position="144"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_046183" evidence="41">
<location>
<begin position="145"/>
<end position="1304"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with RBM39; when associated with A-218; A-232; A-254; A-293; A-310 and A-338." evidence="35">
<original>W</original>
<variation>A</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with RBM39; when associated with A-200; A-232; A-254; A-293; A-310 and A-338." evidence="35">
<original>W</original>
<variation>A</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with RBM39; when associated with A-200; A-218; A-254; A-293; A-310 and A-338." evidence="35">
<original>W</original>
<variation>A</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight inhibition of interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight inhibition of interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with RBM39; when associated with A-200; A-218; A-232; A-293; A-310 and A-338." evidence="35">
<original>W</original>
<variation>A</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight inhibition of interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with RBM39; when associated with A-200; A-218; A-232; A-254; A-310 and A-338." evidence="35">
<original>W</original>
<variation>A</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with RBM39; when associated with A-200; A-218; A-232; A-254; A-293 and A-338." evidence="35">
<original>W</original>
<variation>A</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PPP1R8." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with RBM39; when associated with A-200; A-218; A-232; A-254; A-293 and A-310." evidence="35">
<original>W</original>
<variation>A</variation>
<location>
<position position="338"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect the stability of the SF3B complex interaction with U2AF65. Does not decrease the affinity to RNA." evidence="37">
<original>K</original>
<variation>E</variation>
<location>
<position position="700"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC97189." ref="1" evidence="42">
<original>A</original>
<variation>V</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC97189." ref="1" evidence="42">
<original>R</original>
<variation>L</variation>
<location>
<position position="594"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="380"/>
<end position="394"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="401"/>
<end position="406"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="410"/>
<end position="414"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="461"/>
<end position="464"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="469"/>
<end position="471"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="472"/>
<end position="474"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="476"/>
<end position="478"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="484"/>
<end position="487"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="494"/>
<end position="505"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="509"/>
<end position="521"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="523"/>
<end position="526"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="528"/>
<end position="540"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="546"/>
<end position="562"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="564"/>
<end position="566"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="568"/>
<end position="570"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="571"/>
<end position="578"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="579"/>
<end position="583"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="587"/>
<end position="603"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="606"/>
<end position="613"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="615"/>
<end position="618"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="622"/>
<end position="639"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="641"/>
<end position="651"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="658"/>
<end position="675"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="676"/>
<end position="682"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="683"/>
<end position="690"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="691"/>
<end position="694"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="699"/>
<end position="716"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="722"/>
<end position="727"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="728"/>
<end position="737"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="741"/>
<end position="753"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="754"/>
<end position="756"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="759"/>
<end position="775"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="776"/>
<end position="778"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="782"/>
<end position="795"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="798"/>
<end position="801"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="803"/>
<end position="809"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="811"/>
<end position="817"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="821"/>
<end position="823"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="827"/>
<end position="844"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="846"/>
<end position="854"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="855"/>
<end position="858"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="862"/>
<end position="878"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="886"/>
<end position="901"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="908"/>
<end position="921"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="922"/>
<end position="928"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="929"/>
<end position="940"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="942"/>
<end position="944"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="945"/>
<end position="963"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="964"/>
<end position="966"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="968"/>
<end position="979"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="980"/>
<end position="983"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="987"/>
<end position="1003"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1006"/>
<end position="1008"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1013"/>
<end position="1020"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1022"/>
<end position="1025"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1029"/>
<end position="1044"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1048"/>
<end position="1050"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1052"/>
<end position="1062"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1063"/>
<end position="1067"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1071"/>
<end position="1088"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1090"/>
<end position="1102"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1105"/>
<end position="1107"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1110"/>
<end position="1122"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1125"/>
<end position="1137"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1141"/>
<end position="1158"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1159"/>
<end position="1164"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1166"/>
<end position="1177"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1178"/>
<end position="1180"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1182"/>
<end position="1199"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1205"/>
<end position="1215"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1216"/>
<end position="1219"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1224"/>
<end position="1241"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1243"/>
<end position="1250"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1252"/>
<end position="1254"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1259"/>
<end position="1274"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1279"/>
<end position="1282"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1299"/>
<end position="1301"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3LQV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IFE"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6EN4"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6FF4"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17924679"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000250"/>
<evidence key="22" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q99NB9"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10882114"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11991638"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12105215"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12234937"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12738865"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15146077"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16432215"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16603771"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17589525"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21062891"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21700224"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23512658"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24795046"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26575292"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27720643"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28541300"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9585501"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source ref="36"/>
</evidence>
<evidence key="41" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="42" type="ECO:0000305"/>
<evidence key="43" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12105215"/>
</source>
</evidence>
<sequence length="1304" mass="145830" checksum="12F051757D2B9DEE" modified="2009-11-24" version="3">MAKIAKTHEDIEAQIREIQGKKAALDEAQGVGLDSTGYYDQEIYGGSDSRFAGYVTSIAATELEDDDDDYSSSTSLLGQKKPGYHAPVALLNDIPQSTEQYDPFAEHRPPKIADREDEYKKHRRTMIISPERLDPFADGGKTPDPKMNARTYMDVMREQHLTKEEREIRQQLAEKAKAGELKVVNGAAASQPPSKRKRRWDQTADQTPGATPKKLSSWDQAETPGHTPSLRWDETPGRAKGSETPGATPGSKIWDPTPSHTPAGAATPGRGDTPGHATPGHGGATSSARKNRWDETPKTERDTPGHGSGWAETPRTDRGGDSIGETPTPGASKRKSRWDETPASQMGGSTPVLTPGKTPIGTPAMNMATPTPGHIMSMTPEQLQAWRWEREIDERNRPLSDEELDAMFPEGYKVLPPPAGYVPIRTPARKLTATPTPLGGMTGFHMQTEDRTMKSVNDQPSGNLPFLKPDDIQYFDKLLVDVDESTLSPEEQKERKIMKLLLKIKNGTPPMRKAALRQITDKAREFGAGPLFNQILPLLMSPTLEDQERHLLVKVIDRILYKLDDLVRPYVHKILVVIEPLLIDEDYYARVEGREIISNLAKAAGLATMISTMRPDIDNMDEYVRNTTARAFAVVASALGIPSLLPFLKAVCKSKKSWQARHTGIKIVQQIAILMGCAILPHLRSLVEIIEHGLVDEQQKVRTISALAIAALAEAATPYGIESFDSVLKPLWKGIRQHRGKGLAAFLKAIGYLIPLMDAEYANYYTREVMLILIREFQSPDEEMKKIVLKVVKQCCGTDGVEANYIKTEILPPFFKHFWQHRMALDRRNYRQLVDTTVELANKVGAAEIISRIVDDLKDEAEQYRKMVMETIEKIMGNLGAADIDHKLEEQLIDGILYAFQEQTTEDSVMLNGFGTVVNALGKRVKPYLPQICGTVLWRLNNKSAKVRQQAADLISRTAVVMKTCQEEKLMGHLGVVLYEYLGEEYPEVLGSILGALKAIVNVIGMHKMTPPIKDLLPRLTPILKNRHEKVQENCIDLVGRIADRGAEYVSAREWMRICFELLELLKAHKKAIRRATVNTFGYIAKAIGPHDVLATLLNNLKVQERQNRVCTTVAIAIVAETCSPFTVLPALMNEYRVPELNVQNGVLKSLSFLFEYIGEMGKDYIYAVTPLLEDALMDRDLVHRQTASAVVQHMSLGVYGFGCEDSLNHLLNYVWPNVFETSPHVIQAVMGALEGLRVAIGPCRMLQYCLQGLFHPARKVRDVYWKIYNSIYIGSQDALIAHYPRIYNDDKNTYIRYELDYIL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

